The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8 T Cell Fitness and Functionality.
Clicks: 312
ID: 46883
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
74.6
/100
312 views
249 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Tissue-resident memory CD8 T (Trm) cells share core residency gene programs with tumor-infiltrating lymphocytes (TILs). However, the transcriptional, metabolic, and epigenetic regulation of Trm cell and TIL development and function is largely undefined. Here, we found that the transcription factor Bhlhe40 was specifically required for Trm cell and TIL development and polyfunctionality. Local PD-1 signaling inhibited TIL Bhlhe40 expression, and Bhlhe40 was critical for TIL reinvigoration following anti-PD-L1 blockade. Mechanistically, Bhlhe40 sustained Trm cell and TIL mitochondrial fitness and a functional epigenetic state. Building on these findings, we identified an epigenetic and metabolic regimen that promoted Trm cell and TIL gene signatures associated with tissue residency and polyfunctionality. This regimen empowered the anti-tumor activity of CD8 T cells and possessed therapeutic potential even at an advanced tumor stage in mouse models. Our results provide mechanistic insights into the local regulation of Trm cell and TIL function.Reference Key |
li2019theimmunity
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Li, Chaofan;Zhu, Bibo;Son, Young Min;Wang, Zheng;Jiang, Li;Xiang, Min;Ye, Zhenqing;Beckermann, Kathryn E;Wu, Yue;Jenkins, James W;Siska, Peter J;Vincent, Benjamin G;Prakash, Y S;Peikert, Tobias;Edelson, Brian T;Taneja, Reshma;Kaplan, Mark H;Rathmell, Jeffrey C;Dong, Haidong;Hitosugi, Taro;Sun, Jie; |
Journal | immunity |
Year | 2019 |
DOI | S1074-7613(19)30364-4 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.